Tough year in France as industry battles with politics
This article was originally published in Clinica
Executive Summary
The French health service, reputed to offer the best care in Europe, is now increasingly crippled by debts. As the government seeks to constrain costs, the medical devices industry is having to fight a growing number of battles to ensure that it does not bear the brunt of having to finance the shortfall. Amanda Maxwell reports
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.